A Bioequivalence Study Using Clinical Endpoint for Diclofenac Sodium Gel 1% in Osteoarthritis Knee"

NCT03172780 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1220

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

DRUG: Diclofenac sodium gel 1%
DRUG: Voltaren® Gel (Diclofenac Sodium Topical Gel) 1%
DRUG: Placebo gel

Sponsor

Mylan Pharmaceuticals Private Limited